National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AA29	XELJANZ XR	B	Tofacitinib - 11mg	11mg	Tablet, extended release	78,687,316 L.L
M03AX01	XEOMIN	BioTech	Clostridium botulinum type A neurotoxin complex - 100 units LD50	100 units LD50	Injectable powder for solution	20,517,541 L.L
M03AX01	XEOMIN	BioTech	Clostridium botulinum type A neurotoxin complex - 50 units LD50	50 units LD50	Injectable powder for solution	11,920,109 L.L
M05BX04	XGEVA	BioTech	Denosumab - 120mg	120mg	Injectable solution	33,545,669 L.L
N05AX12	XALIPRO	G	Aripiprazole - 10mg	10mg	Tablet	2,123,271 L.L
N05AX12	XALIPRO	G	Aripiprazole - 15mg	15mg	Tablet	2,418,917 L.L
N05AX12	XALIPRO	G	Aripiprazole - 5mg	5mg	Tablet	1,746,995 L.L
N05BA12	XANAX	B	Alprazolam - 0.5mg	0.5mg	Tablet	477,064 L.L
R01AA07	XYLO-COMOD	G	Xylometazoline HCl - 0.1%	0.1%	Solution	499,909 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable lyophilised powder for solution+diluent	54,613,625 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable solution	37,110,724 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable solution	L.L
R06AE09	XYZAL	B	Levocetirizine dihydrochloride - 5mg	5mg	Tablet, film coated	572,477 L.L
S01ED51	XOLAMOL	G	Timolol (maleate) - 5mg/ml, Dorzolamide HCl - 20mg/ml		Drops solution	678,640 L.L
S01ED51	XALACOM	B	Timolol (maleate) - 6.8mg/ml, Latanoprost - 50?g/ml		Drops solution	510,660 L.L
S01EE01	XALATAN	B	Latanoprost - 50mcg/ml	50mcg/ml	Drops solution	704,173 L.L
S01EE01	XALAPROST	G	Latanoprost - 0.005% w/v	0.005% w/v	Drops solution	421,967 L.L